News
12-12-2014, 03:38 AM
The preventive effect of breast cancer drug 'tamoxifen' remains virtually constant for at least 20 years - with rates reduced by around 30 per cent - new analysis published in The Lancet Oncology reveals.
More... (http://www.news-medical.net/news/20141212/Preventive-effect-of-tamoxifen-drug-for-breast-cancer-remains-virtually-constant-for-20-years.aspx)
More... (http://www.news-medical.net/news/20141212/Preventive-effect-of-tamoxifen-drug-for-breast-cancer-remains-virtually-constant-for-20-years.aspx)